Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

2012 – Lipitor users 29% more likely to develop diabetes than non-users

Posted in Lipitor

In 2012, an article titled “Statins and new-onset diabetes: a retrospective longitudinal cohort study.” published in Clinical Therapeutics by T. Ma et al. aimed to “investigate the association between statins and NOD.” (NOD stands for new onset diabetes, and “statins” are a class of cholesterol-lowering drugs including Crestor, Lipitor, and others.)

This study was “a retrospective cohort study performed by using data from claim forms provided to the central regional branch of the Bureau of National Health Insurance in Taiwan from July 2006 to December 2009” and “estimated the hazards ratios (HRs) of NOD associated with statin use. Nondiabetic subjects served as the reference group.”

In all, 1,350 patients were identified with new onset diabetes among a total group of 16,000 patients with either hypertension or dyslipidemia.  Using statistics, the study team found that the “risk of NOD after adjusting for sex and age was higher among users of pravastatin (HR, 1.34 [95% CI, 1.15-1.55]) and atorvastatin (HR, 1.29 [95% CI, 1.16-1.44]) than among nonusers.”  This means that patients who used pravastatin (Pravachol) were 34% more likely than nonusers to develop diabetes, and that patients who used Lipitor were 29% more likely to develop diabetes.

Since Pfizer, the manufacturer of Lipitor, has failed to make clear the increased risk for diabetes associated with Lipitor on the Lipitor Warning Label (even after the FDA announced that diabetes has been associated with Lipitor use), Lipitor lawsuits have been filed across the country and around the world.

If you used Lipitor and were recently diagnosed with diabetes, you may be eligible to file a Lipitor lawsuit to gain significant financial compensation from Pfizer for its failure to act in the interest of its patients. The publication of studies like the one summarized above illustrates that Pfizer knew, or should have known, that Lipitor is associated with diabetes.

For more information, or a free no-obligation Lipitor lawsuit consultation, contact our team of Lipitor lawyers at the information provided below.  We have the experience, skill, and resources required to win the justice you deserve, even from the largest of drug manufacturers.  Call today and see how we can help.

(855) 452 – 5529

justinian@dangerousdrugs.us

Our Lipitor Lawsuit Information page is a great place to start if you have any questions about Lipitor.